Femhrt combined with Premarin

Reports:

Reaction Outcome Event Date Age Sex Weight Reported Reporter Country Treatment
Role Name
Neoplasm Malignant Other Serious Female 1/11/2006 Consumer United States
Primary
Secondary
Breast Cancer Metastatic Other Serious Female 1/13/2006 United States
Primary
Secondary
Stress Fracture Other Serious 7/1/2001 59 Female 154 lb 2/6/2006 Physician United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 7/18/2003 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 3/2/2005 53 Female 12/23/2005 United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 2/23/2004 Female 12/23/2005 United States
Primary
Secondary
Cerebrovascular Accident Other Serious 7/30/1999 Female 12/23/2005 United States
Primary
Secondary
Ovarian Cancer Other Serious 3/31/2003 63 Female 12/23/2005 United States
Primary
Secondary
Neoplasm Progression Other Serious Female 2/3/2006 Lawyer United States
Primary
Secondary
Pulmonary Embolism Other Serious 12/18/2001 62 Female 135 lb 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 12/1/2002 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 7/1/2003 Female 12/23/2005 United States
Primary
Secondary
Ovarian Cancer Other Serious 1/1/2004 Female 12/23/2005 United States
Primary
Secondary
Ovarian Cancer Other Serious 1/1/1995 40 Female 160 lb 12/23/2005 United States
Primary
Secondary
Concomitant
Metastasis Other Serious Female 2/21/2006 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious Female 2/24/2006 Lawyer United States
Primary
Secondary
Metastases To Peripheral Vascular System Other Serious Female 2/28/2006 United States
Primary
Secondary
Breast Cancer Metastatic Other Serious Female 3/6/2006 United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 4/27/2004 76 Female 3/6/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 3/6/2006 United States
Primary
Secondary
Vaginal Haemorrhage Other Serious 4/4/2001 50 Female 175 lb 3/6/2006 United States
Primary
Secondary
Transient Ischaemic Attack Hospitalization 10/1/2001 61 Female 187 lb 3/28/2006 Lawyer United States
Primary
Concomitant
Progesterone Receptor Assay Positive Other Serious 3/4/2004 60 Female 3/29/2006 United States
Primary
Secondary
Oestrogen Receptor Assay Positive Other Serious 11/12/2002 61 Female 4/13/2006 United States
Primary
Secondary
Vomiting Other Serious 7/9/2002 77 Female 130 lb 4/21/2006 United States
Primary
Secondary
Breast Cancer Female Death 4/12/2004 62 Female 5/3/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 5/12/2004 57 Female 5/5/2006 United States
Primary
Secondary
Oestrogen Receptor Assay Positive Other Serious 7/18/2003 57 Female 122 lb 5/5/2006 United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious 4/12/2004 62 Female 5/16/2006 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 8/1/2001 Female 3/7/2006 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious 4/12/2004 62 Female 5/23/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 5/26/2004 58 Female 6/14/2006 Lawyer United States
Primary
Secondary
Cerebrovascular Accident Other Serious 7/30/1999 Female 4/20/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 5/26/2004 58 Female 6/21/2006 United States
Primary
Secondary
Breast Cancer Metastatic Other Serious 7/18/2003 57 Female 122 lb 7/20/2006 United States
Primary
Secondary
Vaginal Haemorrhage Other Serious 3/8/2001 50 Female 175 lb 7/20/2006 United States
Primary
Secondary
Breast Cancer Required Intervention Female 6/15/2006 Lawyer United States
Primary
Secondary
Breast Cancer Metastatic Required Intervention Female 7/7/2006 Consumer United States
Primary
Secondary
Oestrogen Receptor Assay Positive Other Serious 7/18/2003 57 Female 122 lb 7/31/2006 United States
Primary
Secondary
Breast Cancer Other Serious 7/18/2003 Female 7/21/2006 Lawyer United States
Primary
Secondary
Breast Cancer Required Intervention 3/2/2005 53 Female 7/21/2006 Consumer United States
Primary
Secondary
Breast Cancer Hospitalization Female 7/21/2006 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 1/1/2004 60 Female 7/21/2006 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 1/1/2004 74 Female 7/21/2006 Consumer United States
Primary
Secondary
Breast Cancer In Situ Required Intervention 11/12/2002 61 Female 7/21/2006 United States
Primary
Secondary
Breast Cancer In Situ Required Intervention 2/14/2001 63 Female 7/21/2006 United States
Primary
Secondary
Breast Cancer Other Serious 5/12/2004 57 Female 7/21/2006 Consumer United States
Primary
Secondary
Breast Cancer In Situ Required Intervention 5/30/2001 66 Female 7/21/2006 United States
Primary
Secondary
Cerebrovascular Accident Other Serious 7/30/1999 Female 7/21/2006 United States
Primary
Secondary
Breast Cancer Other Serious 2/1/2002 55 Female 8/14/2006 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious 2/1/2002 55 Female 8/14/2006 Lawyer United States
Primary
Secondary
Rhabdomyolysis Other Serious 2/25/2002 69 Female 117 lb 8/22/2006 Physician United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious 2/1/2002 51 Female 8/18/2006 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious 7/1/2004 Female 8/22/2006 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious 1/1/2005 Female 8/22/2006 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious 2/26/2003 Female 8/29/2006 United States
Primary
Secondary
Oestrogen Receptor Assay Positive Other Serious 8/8/2000 54 Female 122 lb 9/5/2006 United States
Primary
Secondary
Breast Cancer Other Serious 4/1/2004 72 Female 9/6/2006 United States
Primary
Secondary
Breast Cancer Other Serious 8/1/2001 53 Female 135 lb 10/10/2006 United States
Primary
Secondary
Breast Cancer Other Serious Female 10/10/2006 United States
Primary
Secondary
Breast Cancer Other Serious 6/1/2001 Female 165 lb 2/22/2007 United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 5/26/2004 58 Female 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious 4/27/2004 75 Female 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious 5/12/2004 57 Female 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious 4/1/2004 70 Female 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious 2/1/2002 55 Female 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious 7/23/2003 60 Female 154 lb 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious 1/1/2005 Female 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious 7/1/2004 Female 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious 3/4/2004 60 Female 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious 11/12/2002 61 Female 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious Female 12/22/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 1/1/2003 Female 4/18/2007 Lawyer United States
Primary
Secondary
Breast Cancer Metastatic Other Serious 10/16/2001 Female 5/24/2007 Consumer United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Endometrial Cancer Death 5/1/2002 7/31/2007 Lawyer United States
Primary
Concomitant
Breast Cancer Metastatic Required Intervention 9/27/2002 75 Female 144 lb 7/5/2007 Consumer United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 8/15/2001 Female 8/17/2007 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 5/26/2004 58 Female 7/18/2007 United States
Primary
Secondary
Breast Cancer Other Serious 7/1/2004 Female 7/18/2007 United States
Primary
Secondary

Drug Data